Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Minhong Biotech is a specialized biotechnology company focused on the development and application of droplet microfluidic technology for high-throughput biological screening. Based in Shanghai, the company provides a proprietary platform that enables the rapid analysis and sorting of single cells, antibodies, and enzymes at an unprecedented scale. Their technology is primarily utilized in antibody discovery, enzyme engineering, and synthetic biology to accelerate the identification of high-performing biological candidates. Minhong offers both integrated hardware solutions and contract research services to pharmaceutical and industrial partners. By significantly reducing the time and cost associated with traditional screening methods, the company aims to streamline the early-stage R&D process for complex biologics. Their platform integrates microfluidics with advanced imaging and automated sorting to identify rare, high-value biological candidates from massive libraries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Minhong Technology.